At the time of writing, PMV Pharmaceuticals Inc [PMVP] stock is trading at $1.4, down -2.78%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PMVP shares have lost -5.41% over the last week, with a monthly amount drifted -1.41%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
PMV Pharmaceuticals Inc [NASDAQ: PMVP] stock has seen the most recent analyst activity on November 08, 2024, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $6 for it. Previously, Craig Hallum started tracking the stock with Buy rating on May 13, 2024, and set its price target to $6. On April 12, 2024, Jefferies initiated with a Buy rating and assigned a price target of $5 on the stock. Ladenburg Thalmann started tracking the stock assigning a Buy rating and suggested a price target of $7 on December 27, 2023. Oppenheimer upgraded its rating to a Outperform but $30 remained the price target by the analyst firm on March 02, 2022. Goldman upgraded its rating to Buy for this stock on September 22, 2021, and upped its price target to $43. In a note dated August 19, 2021, Oppenheimer initiated an Perform rating.
For the past year, the stock price of PMV Pharmaceuticals Inc fluctuated between $0.81 and $1.82. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. PMV Pharmaceuticals Inc [NASDAQ: PMVP] shares were valued at $1.4 at the most recent close of the market. An investor can expect a potential return of 1185.71% based on the average PMVP price forecast.
Analyzing the PMVP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.48 and Total Capital is -0.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3767 points at the first support level, and at 1.3533 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4367, and for the 2nd resistance point, it is at 1.4733.
Ratios To Look Out For
It is important to note that PMV Pharmaceuticals Inc [NASDAQ:PMVP] has a current ratio of 12.52. As well, the Quick Ratio is 12.52, while the Cash Ratio is 3.8.
Transactions by insiders
Recent insider trading involved Ticktin Robert, General Counsel & COO, that happened on Jul 01 ’25 when 23151.0 shares were sold. Chief Development Officer, Jalota Deepika completed a deal on Jul 01 ’25 to sell 33065.0 shares. Meanwhile, Chief Financial Officer Carulli Michael sold 28249.0 shares on Jul 01 ’25.
